查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988103

自動化微生物市場：依技術、產品、自動化程度、應用和最終用戶分類－2026-2032年全球市場預測

Automated Microbiology Market by Technology, Product, Automation Level, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年自動化微生物市場價值為 140.3 億美元，預計到 2026 年將成長至 157.4 億美元，複合年成長率為 12.39%，到 2032 年將達到 317.9 億美元。

主要市場統計數據
基準年 2025 140.3億美元
預計年份：2026年 157.4億美元
預測年份 2032 317.9億美元
複合年成長率 (%) 12.39%

為檢查室管理人員提供自動化微生物學的策略指南，明確技術整合、營運重點和實際實施途徑。

自動化微生物學已從增強特定檢查室能力發展成為擴充性、可靠的診斷和分析工作流程的核心基礎。光學成像、分子檢測、質譜和資訊學的進步融合在一起，縮短了結果獲取時間，減少了人為差異，並在臨床診斷、食品安全、環境監測和生物製藥品管等領域開闢了新的應用情境。隨著檢查室面臨檢體量不斷增加、監管要求日益嚴格以及熟練技術人員短缺等問題，對自動化的投資正在提高檢測能力和可重複性，並促使實驗室重新評估其營運重點。

分子檢測、質譜、智慧軟體和供應鏈設計等領域的進步如何融合，從而重新定義實驗室自動化策略。

自動化微生物學領域正經歷一系列變革性變化，這些變化正在改變檢查室評估價值和衡量績效的方式。其中一個主要驅動力是分子技術的成熟，這些技術已超越概念概念驗證階段，發展成為實用且整合的工作流程。次世代定序和先進的PCR平台正日益融入常規診斷和監測流程，它們並非取代傳統培養方法，而是對其進行補充。同時，質譜鑑定技術和高通量流式細胞技術的進步，正在拓展可快速、可重複分析的微生物和檢體範圍。

關稅累積變化導致的營運和採購調整正在影響籌資策略、總擁有成本 (TCO) 概念和恢復措施。

到了2025年，貿易政策的發展和關稅調整對實驗室設備、耗材和整合系統的採購和部署產生累積影響。由於進口零件和成品設備關稅上漲導致成本上升，採購團隊正在重新評估其供應商組合，並探索優先簽訂長期合約以降低價格波動、並傾向於區域性製造商和國內成熟經銷商的替代籌資策略。這種轉變使得採購決策更加關注整體擁有成本（TCO），而不僅僅是採購價格，因為前置作業時間、維護合約和備件供應情況等因素在採購決策中變得越來越重要。

一種基於精細細分的觀點技術平台、產品類型、實驗室應用和自動化成熟度與實際部署模式連結起來。

詳細的細分分析揭示了不同技術、產品、應用、終端使用者和自動化程度下的應用模式和價值來源的差異。在技​​術層面，基於培養的方法仍然是表現型確認的核心，並且正透過自動化菌落計數器、自動化培養系統以及自動化染色和顯微鏡技術進行最佳化，以減少人工操作時間並提高結果的可重複性。流式細胞技術可為環境和臨床應用提供快速的細胞和顆粒分析，而質譜分析則能夠對複雜樣本進行高精度鑑定。諸如微陣列、次世代定序和PCR/即時PCR等分子生物學技術正在拓展診斷應用範圍，實現先前難以大規模實現的基因組監測和多重檢測。

區域監管差異、基礎設施投資和經銷夥伴關係如何塑造美洲、歐洲、中東、非洲和亞太地區的不同採用路徑。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的自動化微生物檢測的採用、監管路徑和商業策略有顯著影響。在美洲，需求往往受到醫療基礎設施的異質性、臨床卓越中心的集中分佈以及能夠支援大規模自動化部署的整合型醫院網路的影響。北美採購團隊優先考慮與醫院資訊系統的互通性以及對當地監管要求的合規性，而拉丁美洲市場則兼具集中式參考檢查室和新興的分散式檢查需求，這影響著產品配置和服務模式。

產品效能、軟體整合、驗證支援和服務模式推動長期採用和供應商選擇，從而形成競爭與合作的動態。

自動化微生物檢測領域的競爭動態由專業儀器製造商、整合系統供應商、試劑和耗材供應商以及服務機構共同構成。市場領導透過整合儀器性能、軟體整合、驗證支援以及全球服務網路來脫穎而出，從而最大限度地減少停機時間並確保可追溯性。儀器原始設備製造商 (OEM) 與試劑合作夥伴之間的策略合作日益普遍，由此產生的捆綁式解決方案簡化了採購和驗證流程，但也引發了人們對供應商鎖定和互通性的擔憂。

為領導者提供實用且具戰術性的建議，結合分階段自動化、採購彈性、互通性、人才發展和夥伴關係策略。

產業領導者必須推動一系列綜合舉措，使技術選擇與營運韌性和法規遵循保持一致。首先，應採取分階段的自動化策略，從試點部署開始，驗證工作流程整合、檢測法可重複使用性以及員工培訓要求，然後再檢驗到全自動化系統。這可以降低部署風險，並隨著偵測需求和供應鏈狀況的變化而保持靈活性。其次，應設計採購和合約方案，重點關注整體擁有成本、可預測的服務水準以及備件和試劑的明確供應保障，以降低關稅和物流波動帶來的風險。

採用嚴謹的混合方法研究途徑，結合關鍵相關人員的訪談、同儕審查的技術證據以及有針對性的技術和商業評估。

本執行摘要的研究結合了對實驗室經理、採購經理、臨床病理學家和高級研發科學家的定性訪談，以及對技術文獻、監管指導文件和產品技術文件的系統性回顧。主要訪談旨在揭示營運挑戰、驗證實踐和採購行為，重點關注實際營運挑戰，例如檢體處理能力、員工能力和維護物流的差異。輔助資訊的選擇強調嚴謹的調查方法，包括同行評審的研究、公開的監管指導和供應商的技術規範，以全面檢驗性能和預期用途聲明。

將決定臨床、工業和實驗室環境中自動化實施成功與否的策略挑戰和營運現實相結合。

自動化微生物學正處於技術成熟度、營運壓力和監管要求交匯的十字路口，為檢查室決策者帶來了新的挑戰。改進的分子檢測工作流程、先進的鑑定技術和更智慧的軟體生態系統相結合，正在推動臨床、工業和研究領域進行更可靠、擴充性的檢測。儘管具體的實施路徑會因應用、最終用戶和當地情況而異，但互通性、供應鏈韌性、人力資源準備和檢驗等通用要素始終是成功部署的關鍵。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 自動化微生物市場：依技術分類

  • 文化基礎
    • 自動菌落計數器
    • 自動化培養系統
    • 自動化染色和顯微鏡
  • 流式細胞技術
  • 質譜分析
  • 基於分子
    • 微陣列
    • 次世代定序
    • PCR/即時PCR

第9章 自動化微生物市場：依產品分類

  • 耗材和試劑
  • 設備和軟體
    • 整合系統
    • 檢查資訊管理系統
    • 獨立設備
  • 服務

第10章：自動化微生物市場：依自動化程度分類

  • 全自動
  • 半自動

第11章 自動化微生物市場：依應用領域分類

  • 學術研究和調查
  • 臨床診斷
    • 遺傳性疾病
    • 感染疾病
    • 腫瘤學
  • 環境測試
  • 食品/飲料
  • 製藥和生物技術

第12章：自動化微生物市場：依最終用戶分類

  • 學術和研究機構
  • 食品和飲料製造商
  • 醫院和診斷檢測機構
    • 診所
    • 私立醫院
    • 公立醫院
  • 製藥公司
  • 標準檢驗組織

第13章：自動化微生物市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：自動化微生物市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：自動化微生物市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國自動化微生物市場

第17章：中國自動化微生物市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Accelerate Diagnostics, Inc.
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company（BD）
  • BIOMERIEUX
  • bioMerieux Industry
  • bioMerieux SA
  • Bruker Corporation
  • Cepheid Inc.
  • Copan Diagnostics Inc.
  • COPAN Diagnostics, Inc.
  • Danaher Corporation
  • Hardy Diagnostics
  • Labcompare
  • Luminex Corporation
  • Merck KGaA
  • Neogen Corporation
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific Inc.
  • Whitelake Software Point Oy
Product Code: MRR-F97DD5A7DBA7

The Automated Microbiology Market was valued at USD 14.03 billion in 2025 and is projected to grow to USD 15.74 billion in 2026, with a CAGR of 12.39%, reaching USD 31.79 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.03 billion
Estimated Year [2026] USD 15.74 billion
Forecast Year [2032] USD 31.79 billion
CAGR (%) 12.39%

A strategic orientation to automated microbiology that clarifies technology convergence, operational priorities, and practical adoption pathways for laboratory leaders

Automated microbiology has evolved from a niche laboratory enhancement into a core enabler of scalable, reliable diagnostic and analytical workflows. Advances across optical imaging, molecular detection, mass spectrometry, and informatics have converged to shorten time-to-result, reduce human variability, and unlock new use cases in clinical diagnostics, food safety, environmental monitoring, and biopharmaceutical quality control. As laboratories contend with increasing sample volumes, tighter regulatory demands, and a shortage of trained technicians, automation investments deliver both throughput and reproducibility gains, reshaping operational priorities.

This executive summary frames the current landscape by synthesizing technology trajectories, commercial dynamics, and operational considerations that matter to C-suite and laboratory leaders. It identifies how incremental innovations-such as automated colony counters that feed downstream digital analysis, or integrated sequencing workflows that reduce hands-on time-are compounding to create new value propositions. Equally important are the system-level integrations that connect instruments to laboratory information management systems and digital dashboards, enabling real-time decision support. Throughout, emphasis is placed on practical adoption pathways: pilot designs, validation considerations, and cross-functional governance that ensure automated solutions deliver measurable improvements without disrupting core quality controls.

The objective is to equip decision-makers with a clear, actionable view of where automated microbiology capabilities are today, how they are likely to be deployed in operational settings, and which organizational levers accelerate adoption while maintaining compliance and clinical or analytical fidelity.

How converging advances in molecular assays, mass spectrometry, intelligent software, and supply chain design are redefining laboratory automation strategies

The automated microbiology landscape is being reshaped by several transformative shifts that collectively alter how laboratories assess value and measure performance. A primary driver is the maturation of molecular technologies that have moved beyond proof-of-concept to practical, integrated workflows; next-generation sequencing and advanced PCR platforms are increasingly embedded within routine diagnostic and surveillance pipelines, complementing classical culture-based methods rather than replacing them. At the same time, improvements in mass spectrometry identification and high-throughput flow cytometry have expanded the breadth of organisms and sample types that can be analyzed rapidly and reproducibly.

Concurrently, software and systems integration have become decisive differentiators. Laboratory information management systems and integrated instrument suites now enable closed-loop workflows where sample metadata, instrument outputs, and quality control records are synchronized, enabling faster root-cause analysis and regulatory traceability. Artificial intelligence and machine learning are making early inroads into image-based colony counting and spectral interpretation, improving automated decision rules while lowering the need for manual annotation. Supply chain resilience and reagent availability are stimulating modular automation approaches that let laboratories scale selectively, adopting semi-automated instruments initially before migrating to fully automated platforms as workflows mature.

Regulatory and reimbursement pathways are also evolving; agencies are placing greater emphasis on traceability, method validation, and post-market surveillance of automated systems. Together, these shifts are converging to create an environment where automation decisions are driven by a combination of clinical or analytical need, operational constraints, and an ecosystem approach to software and consumable partnerships.

Operational and procurement adjustments driven by cumulative tariff changes that are shaping sourcing strategies, total cost of ownership thinking, and resilience measures

Trade policy developments and tariff adjustments enacted through 2025 have had a cumulative effect on the procurement and deployment of laboratory instruments, consumables, and integrated systems. Tariff-induced cost increases for imported components and finished instruments have prompted procurement teams to reassess supplier portfolios, emphasize long-term contracts to mitigate price volatility, and consider alternative sourcing strategies that prioritize regional manufacturing or distributors with established domestic inventories. This shift has also heightened attention to total cost of ownership rather than headline purchase price, as lead times, servicing arrangements, and spare parts availability factor more prominently into procurement decisions.

Manufacturers and distributors have responded with a range of adaptations, including localized assembly, selective redesign to reduce tariff-sensitive content, and increased stocking of critical reagents and mission-critical spare parts within domestic warehouses. For laboratories, the net effect is a more cautious approach to capital expenditures and a preference for modular systems that can be upgraded incrementally. Lifecycle management practices, such as multi-site service agreements and shared consumable contracts, are being used to spread financial risk and maintain continuity of operations.

In practice, tariff-driven changes have accelerated conversations around strategic resilience: dual-sourcing critical components, investing in vendor-agnostic interfaces to minimize lock-in, and enhancing regulatory documentation to facilitate faster qualification of alternate suppliers. These measures, combined with more sophisticated scenario planning by procurement and finance teams, are helping laboratories adapt to a commercial environment in which cross-border trade policy is a material factor in operational planning.

A nuanced segmentation-driven perspective that connects technology platforms, product types, laboratory applications, and automation maturity to real-world adoption patterns

Deep segmentation analysis reveals differentiated adoption patterns and value drivers across technology, product, application, end user, and automation level axes. On the technology front, culture-based approaches remain central for phenotypic confirmation and are increasingly optimized through automated colony counters, automated culture systems, and automated staining and microscopy that reduce hands-on time and improve reproducibility. Flow cytometry provides rapid cellular and particulate analysis for environmental and clinical applications, while mass spectrometry offers high-confidence identification for complex samples. Molecular-based modalities such as microarray, next-generation sequencing, and PCR/real-time PCR are expanding diagnostic reach, enabling genomic surveillance and multiplexed detection that were previously impractical at scale.

Product segmentation highlights distinct commercial and operational considerations for consumables and reagents, instruments and software, and services. Integrated systems, laboratory information management systems, and standalone instruments present different implementation footprints and validation requirements, influencing procurement cycles and service models. Application-based segmentation shows that academic and research settings prioritize flexible, research-grade platforms for method development; clinical diagnostics demand robust, validated workflows for genetic disorders, infectious diseases, and oncology; environmental testing and food and beverage sectors emphasize throughput and regulatory traceability; while pharmaceutical and biotechnology users prioritize compliance and batch-level assurance.

End users range from academic and research institutions to hospitals and diagnostic laboratories, food and beverage companies, pharmaceutical firms, and reference laboratories. Hospitals and diagnostic labs often subdivide into clinics, private hospitals, and public hospitals, each with distinct budgetary constraints, regulatory frameworks, and throughput needs. Finally, automation level-whether fully automated or semi-automated-remains a decisive choice driven by laboratory scale, technical expertise, and capital availability, with many organizations adopting hybrid strategies that combine semi-automated modules during transition phases before committing to fully automated suites.

How regional regulatory diversity, infrastructure investment, and distribution partnerships shape distinct adoption pathways across the Americas, Europe Middle East and Africa, and Asia-Pacific

Regional dynamics materially influence technology adoption, regulatory pathways, and commercial strategies in automated microbiology across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, demand is often shaped by healthcare infrastructure heterogeneity, concentrated centers of clinical excellence, and integrated hospital networks that can support larger-scale automation rollouts. North American procurement teams emphasize interoperability with hospital information systems and compliance with regional regulatory expectations, while Latin American markets are characterized by a mix of centralized reference labs and emerging decentralized testing needs, which affect product configuration and service models.

Europe, the Middle East and Africa present a diverse regulatory and market environment where single-market strategies rarely apply uniformly. Western European markets often lead in early adoption of integrated laboratory systems and place a high value on formal method validation and cross-border quality harmonization. Regulatory frameworks in the region require careful navigation, prompting vendors to localize clinical evidence and service offerings. Emerging markets within the region may prioritize cost-effective semi-automated solutions that enable incremental capacity expansion and align with public health initiatives.

Asia-Pacific stands out for rapid infrastructure investment, strong manufacturing ecosystems, and an accelerating appetite for genomics and molecular diagnostics. Adoption patterns range from highly advanced urban reference centers that deploy fully automated sequencing and mass spectrometry workflows to decentralized clinical settings that opt for compact, semi-automated platforms. Across all regions, strategic partnerships between vendors and regional distributors, as well as investments in local technical support and training, are critical enablers of sustained adoption and operational performance.

Competitive and collaborative dynamics where product performance, software integration, validation support, and service models determine long-term adoption and vendor preference

Competitive dynamics in automated microbiology are defined by a mix of specialized instrument manufacturers, integrated systems providers, reagent and consumable suppliers, and service organizations. Market leaders differentiate through a combination of instrument performance, software integration, validation support, and global service networks that minimize downtime and ensure traceability. Strategic alliances between instrument OEMs and reagent partners are increasingly common, creating bundled offerings that simplify procurement and validation but also raise questions about vendor lock-in and interoperability.

Innovation is occurring at multiple layers: at the hardware level with more compact, modular instruments designed for decentralized settings; at the assay level with multiplexed molecular tests and robust sample preparation chemistries; and at the software level where analytics, quality control algorithms, and LIMS integration drive operational value. Service models are likewise evolving, with extended warranties, outcome-based service agreements, and cloud-enabled remote diagnostics becoming standard expectations for high-throughput laboratories. Companies that combine deep domain expertise with scalable support infrastructures gain preference among reference labs and hospital networks, while niche innovators continue to capture specialist segments by focusing on unique assay capabilities or cost-optimized workflows.

Partnerships with academic centers and participation in multi-site validation studies also underpin commercial credibility, particularly for technologies that intersect with clinical decision-making. As competition intensifies, vendors that prioritize open architectures, transparent validation data, and end-user training will be better positioned to convert pilot programs into long-term deployments.

Practical and tactical recommendations for leaders that combine phased automation, procurement resilience, interoperability, workforce development, and partnership strategies

Industry leaders must pursue an integrated set of actions that align technology selection with operational resilience and regulatory readiness. First, adopt a phased automation strategy that begins with pilot deployments to validate workflow integration, method transferability, and staff training requirements before scaling to fully automated suites. This reduces implementation risk and preserves flexibility to pivot as assay needs or supply chain conditions change. Second, design procurement and contracting approaches that emphasize total cost of ownership, predictable service levels, and clear spare parts and reagent supply commitments to mitigate tariff and logistics volatility.

Third, invest in software and data interoperability from the outset to enable seamless integration with laboratory information management systems, electronic health records where applicable, and centralized dashboards for performance monitoring. Open interfaces and standardized data formats reduce long-term integration costs and support multi-vendor environments. Fourth, prioritize workforce development by embedding training programs, competency assessments, and cross-training within implementation plans to ensure laboratory personnel can manage automated workflows, interpret results, and maintain instruments.

Finally, cultivate strategic partnerships with validation partners, regional service providers, and regulatory advisors to accelerate market entry and sustain compliance. Scenario planning that accounts for trade policy shifts, reagent supply interruptions, and staffing constraints will help executives maintain continuity and make informed capital allocation decisions in a landscape where speed, reliability, and traceability confer competitive advantage.

A rigorous mixed-methods research approach combining primary stakeholder interviews, peer-reviewed technical evidence, and targeted technology and commercial assessments

The research underpinning this executive summary combined primary qualitative engagements with laboratory directors, procurement leaders, clinical pathologists, and senior R&D scientists alongside a systematic review of technical literature, regulatory guidance documents, and product technical dossiers. Primary interviews were conducted to surface operational pain points, validation practices, and purchasing behaviors, with emphasis on real-world implementation challenges such as sample throughput variability, staff competency, and maintenance logistics. Secondary sources were selected for methodological rigor and included peer-reviewed studies, open regulatory guidance, and vendor technical specifications to triangulate claims about performance and intended use.

Analytical methods prioritized cross-validation between qualitative insights and documented technical evidence to ensure recommendations are grounded in observable practice rather than vendor positioning. Technology assessments evaluated assay performance characteristics, hands-on time, integration requirements, and typical service footprints. Commercial analysis focused on procurement drivers, contractual structures, and distribution models that affect time-to-deployment. Where possible, evidence from multi-site validation studies and clinical performance evaluations was incorporated to evaluate robustness across diverse laboratory settings.

Limitations of the methodology include variability in reporting granularity across jurisdictions and the evolving nature of software-enabled features, which may shift more rapidly than hardware cycles. To mitigate these limitations, the analysis emphasizes durable operational and strategic themes and recommends targeted pilot studies to validate context-specific performance prior to large-scale rollouts.

Synthesis of strategic imperatives and operational realities that define successful automation deployments in clinical, industrial, and research laboratories

Automated microbiology is at an inflection point where technological maturity, operational pressures, and regulatory demands intersect to create new imperatives for laboratory decision-makers. The combination of improved molecular workflows, advanced identification technologies, and smarter software ecosystems is enabling more reliable and scalable testing across clinical, industrial, and research contexts. Adoption pathways will continue to vary by application, end user, and regional context, but common themes-interoperability, supply chain resilience, workforce readiness, and validated performance-consistently determine successful deployments.

Executives and laboratory leaders should view automation as both a technical upgrade and an organizational transformation that requires deliberate change management, cross-functional governance, and incremental risk mitigation. Where tariffs and trade policy considerations introduce procurement complexity, leaders should prioritize flexibility in sourcing and contractual design to preserve operational continuity. Ultimately, the laboratories that translate automation investments into measurable improvements will be those that combine thoughtful pilots, rigorous validation, and ongoing training with strategic partnerships that support long-term serviceability and compliance.

The insights summarized here are intended to guide strategic planning and to highlight practical levers that accelerate the realization of automation benefits while protecting quality and operational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Automated Microbiology Market, by Technology

  • 8.1. Culture Based
    • 8.1.1. Automated Colony Counters
    • 8.1.2. Automated Culture Systems
    • 8.1.3. Automated Staining & Microscopy
  • 8.2. Flow Cytometry
  • 8.3. Mass Spectrometry
  • 8.4. Molecular Based
    • 8.4.1. Microarray
    • 8.4.2. Next-Gen Sequencing
    • 8.4.3. Pcr/Real-Time Pcr

9. Automated Microbiology Market, by Product

  • 9.1. Consumables & Reagents
  • 9.2. Instruments & Software
    • 9.2.1. Integrated Systems
    • 9.2.2. Laboratory Information Management Systems
    • 9.2.3. Standalone Instruments
  • 9.3. Services

10. Automated Microbiology Market, by Automation Level

  • 10.1. Fully Automated
  • 10.2. Semi-Automated

11. Automated Microbiology Market, by Application

  • 11.1. Academic & Research
  • 11.2. Clinical Diagnostics
    • 11.2.1. Genetic Disorders
    • 11.2.2. Infectious Diseases
    • 11.2.3. Oncology
  • 11.3. Environmental Testing
  • 11.4. Food & Beverage
  • 11.5. Pharmaceutical & Biotechnology

12. Automated Microbiology Market, by End User

  • 12.1. Academic & Research Institutions
  • 12.2. Food & Beverage Companies
  • 12.3. Hospitals & Diagnostic Laboratories
    • 12.3.1. Clinics
    • 12.3.2. Private Hospitals
    • 12.3.3. Public Hospitals
  • 12.4. Pharmaceutical Companies
  • 12.5. Reference Laboratories

13. Automated Microbiology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Automated Microbiology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Automated Microbiology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Automated Microbiology Market

17. China Automated Microbiology Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Accelerate Diagnostics, Inc.
  • 18.7. Agilent Technologies, Inc.
  • 18.8. Beckman Coulter, Inc.
  • 18.9. Becton, Dickinson and Company (BD)
  • 18.10. BIOMERIEUX
  • 18.11. bioMerieux Industry
  • 18.12. bioMerieux SA
  • 18.13. Bruker Corporation
  • 18.14. Cepheid Inc.
  • 18.15. Copan Diagnostics Inc.
  • 18.16. COPAN Diagnostics, Inc.
  • 18.17. Danaher Corporation
  • 18.18. Hardy Diagnostics
  • 18.19. Labcompare
  • 18.20. Luminex Corporation
  • 18.21. Merck KGaA
  • 18.22. Neogen Corporation
  • 18.23. PerkinElmer, Inc.
  • 18.24. QIAGEN N.V.
  • 18.25. Randox Laboratories Ltd.
  • 18.26. Siemens Healthineers AG
  • 18.27. Sysmex Corporation
  • 18.28. T2 Biosystems, Inc.
  • 18.29. Thermo Fisher Scientific Inc.
  • 18.30. Whitelake Software Point Oy

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AUTOMATED MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AUTOMATED MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 215. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 218. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 219. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 220. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 222. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 224. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 248. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 251. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 252. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 253. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 255. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 257. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 259. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 262. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 263. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 264. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 266. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)